Nfu-PA-D4-RNP

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNfu-PA-D4-RNP
Drug Alias Nameanthrax vaccine (Molecular Targeting Technology)
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Targeting Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Targeting Technologies Inc
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A